

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for...
Q2 2026
Aug 6, 2026
Q1 2026
May 14, 2026
FY 2025
Mar 30, 2026
Q4 2025
Mar 30, 2026
Q3 2025
Nov 12, 2025